Stay updated on Nivolumab for ALK+ ALCL: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for ALK+ ALCL: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Recruitment status now shows 'No longer looking for participants', indicating enrollment has ceased. New help sections for reading the study record and joining the study were added, while minor formatting and revision notes were updated.
    Difference
    0.4%
    Check dated 2026-06-14T04:43:29.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a minor site version update. This update is part of the page footer metadata and does not modify the clinical trial details or user-facing content.
    Difference
    0.1%
    Check dated 2026-06-07T00:19:21.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated from v3.5.3 to v3.5.4, indicating a minor update to the page's metadata rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-05-16T10:19:49.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a content management/versioning update rather than changes to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-24T22:20:45.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-17T13:52:54.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The Locations section was updated with new entries for Paris and Villejuif in Val-de-Marne, and some existing address lines were removed or reformatted.
    Difference
    0.9%
    Check dated 2026-04-03T05:31:33.000Z thumbnail image

Stay in the know with updates to Nivolumab for ALK+ ALCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.